Object. Choroid plexus tumors are rare intraventricular tumors (1% of
all intracranial tumors) that occur mainly in children. The pathophysi
ological characteristics of associated hydrocephalus, surgical managem
ent, and oncological issues related to these tumors remain a matter of
debate. To understand more about these tumors, the authors have revie
wed their experience with the management of 38 children with choroid p
lexus tumors. Methods. There were 25 cases of papilloma and 13 of carc
inoma. The mean age of the patients at presentation was 22.5 months, a
nd one-half of the patients were younger than 2 years of age. Hydrocep
halus was present in 33 patients and poorly correlated with the size,
site, and pathological characteristics of the tumor. In nine children,
a ventriculoperitoneal shunt was required after tumor excision, calli
ng into question the notion that cerebrospinal fluid oversecretion is
the only cause of hydrocephalus. Complete excision was achieved in 96%
of the cases of papilloma and 61.5% of the cases of carcinoma. These
surgical procedures were complicated by the risks of intraoperative he
morrhage, which proved to be fatal in two cases, and postoperative bra
in collapse, which led to subdural fluid collections requiring subdura
l shunt placement in six patients. Preoperative embolization was parti
ally successful in four cases and significantly assisted surgery. Preo
perative controlled drainage of excessively dilated ventricles and int
raoperative gluing of the cortical incision have been used to address
the problem of postoperative brain collapse. Patients with carcinomas
were treated postoperatively by chemotherapy alone (seven cases), radi
otherapy (one case), or chemotherapy plus radiotherapy (one case). The
overall 5-year survival rate was 100% for patients with papillomas an
d 40% for those with carcinomas. Conclusions. Total surgical excision
is curative in cases of papillomas. For carcinomas, the most effective
treatment remains total surgical excision; however, adjuvant treatmen
t in the form of chemotherapy in patients younger than age 3 years, su
pplemented by radiation therapy in old er children, can moderately red
uce the risk of recurrence.